Prof. Dr. Gerold Schuler

Medizinische Fakultät Lehrstuhl für Haut- und Geschlechtskrankheiten

GMP-compliant human monocyte-derived dendritic cells for cancer vaccination generated by using the Quantum (R) hollow fiber bioreactor system (2019) Uslu U, Uslu U, Erdmann M, Wiesinger M, Schuler G, Schuler-Thurner B Conference contribution NF-κB activation triggers NK-cell stimulation by monocyte-derived dendritic cells. (2019) Bosch NC, Voll RE, Voskens CJ, Gross S, Seliger B, Schuler G, Schaft N, Dörrie J Journal article Curatopes Melanoma: A Database of Predicted T-cell Epitopes from Overly Expressed Proteins in Metastatic Cutaneous Melanoma. (2019) Lischer C, Eberhardt M, Jaitly T, Schinzel C, Schaft N, Dörrie J, Schuler G, Vera González J Journal article C-reactive protein as an early marker of immune-related adverse events (2019) Abolhassani AR, Schuler G, Kirchberger MC, Heinzerling L Journal article Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response (2019) Toussaint F, Hammon M, Erdmann M, Moreira A, Kirchberger MC, Schuler G, Schett G, Heinzerling L Journal article Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance. (2019) Wiesinger M, Maerz J, Kummer M, Schuler G, Dörrie J, Schuler-Thurner B, Schaft N Journal article ECP as prognostic Marker for Melanoma (2019) Moreira A, Krueckel A, Schuler G, Utikal J, Heinzerling L Conference contribution Blood eosinophilia is an on-treatment biomarker in patients undergoing vaccination with dendritic cells that correlates with long-term patient outcome (2019) Moreira A, Vass V, Erdmann M, Sponagl F, Schuler G, Schuler-Thurner B Conference contribution Do Patients with Lower Limb Melanoma have an increased Risk of a "false negative" Sentinel Node Biopsy? (2019) Braun L, Schellerer V, Schuler G, Goeol J, Erdmann M Conference contribution Successful Treatment of a primary cutaneous aggressive epidermotropic CD8+T-cell Lymphoma with Nivolumab (2019) Toussaint F, Erdmann M, Grosch E, Schuler G, Schliep S, Heinzerling L Conference contribution